Kliinilises uuringus
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
haigus
Haiguse tüüp
Muu
Harva kasutatavate ravimite äratundmine
Jah
Patsiendi tüüp
Täiskasvanud
Lapsed
Kaasamine / välistamine
Rahastamine
era-
Kaasatud liikmed
Teised uurijad
Dr Laura Mauring
Eesti
Dr Philipp Herrmann
Saksamaa
Pr Martin Spitzer
Saksamaa
Dr Johannes Birtel
Saksamaa
Dr Katarina Stingl
Saksamaa
Dr Susanne KOHL
Saksamaa
Dr Giacomo Maria Bacci
Itaalia
Pr Francesca Simonelli
Itaalia
Pr Francesco Testa
Itaalia
ERN EYE liige uurib saiti
HCP: peamised uurijad
Tartu University Hospital, Estonia
Adress
Ludvig Puusepa 8
50406 Tartu
Estonia
Fondation Adolphe de Rothschild, Paris, France
Adress
25-29 Rue Manin
75019 Paris
France
University of Bonn, Germany
Adress
Ernst-Abbe-Strasse 2
53127 Bonn
Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Adress
Martinistraße 52
20251 Hamburg
Germany
Klinikum der Universität München, Germany
Adress
Mathildenstraße 8
80336 Munich
Germany
Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany
Adress
Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7
72076 Tübingen
Germany
Department of Ophthalmology Semmelweis University, Budapest, Hungary
Adress
Mária u. 39
1085 Budapest
Hungary
AOU Careggi – AOU Meyer Consortium, Firenze, Italy
Adress
Largo Brambilla 3
50134 Florence
Italy
AOU Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy
Adress
Via Santa Maria di Costantinopoli
104, 80138 Napoli NA
Italy
University Hospital Graz, Department of Neuro-Ophthalmology, Graz, Austria
Adress
Auenbruggerplatz 4
8036 Graz
Austria